Istanbul University, Faculty of Pharmacy, Department of Pharmacology, Istanbul, Turkey.
Prostaglandins Other Lipid Mediat. 2013 Dec;107:13-7. doi: 10.1016/j.prostaglandins.2013.06.002. Epub 2013 Jun 17.
Perivascular adipose tissue (PVAT) surrounds most vessels and has now been recognized as a regulator of vascular functions. This effect of PVAT has been mostly demonstrated in vessels obtained from rats and mice. Thus, the aim of this study was to investigate anti-contractile effect of PVAT surrounding human coronary bypass grafts such as saphenous vein (SV) and internal mammary artery (IMA). Moreover, we aimed to determine the involvement of prostanoids in the anticontractile effect of PVAT. Human SV and IMA preparations were set up in an organ bath. The presence of PVAT in SV and IMA preparations significantly attenuated the contractile response to noradrenaline (NA). Preincubation with indomethacin, a cyclooxygenase inhibitor, increased NA contraction in SV preparations with PVAT. This effect was not observed in IMA preparation with PVAT incubated with indomethacin. The lower measurements of prostaglandin E2 (PGE2) released from PVAT surrounding IMA versus SV supported these effects. In conclusion, our results show that PVAT of SV could attenuate NA-induced contraction by releasing both PGE2 and prostacyclin (PGI2). In contrast to SV, PVAT of IMA exerts its anti-contractile effect independently from prostanoids. These observations suggest that retaining PVAT in human SV and IMA preparations may have potential clinical implications to improve coronary bypass graft patency.
血管周围脂肪组织 (PVAT) 环绕着大多数血管,现已被认为是血管功能的调节者。这种 PVAT 的作用主要在大鼠和小鼠血管中得到证实。因此,本研究旨在研究人冠状动脉旁路移植血管(如大隐静脉 (SV) 和内乳动脉 (IMA))周围的 PVAT 对血管收缩的抑制作用。此外,我们旨在确定前列腺素在 PVAT 的抗收缩作用中的参与。将人 SV 和 IMA 制剂设置在器官浴中。SV 和 IMA 制剂中存在 PVAT 显著减弱了去甲肾上腺素 (NA) 引起的收缩反应。在有 PVAT 的 SV 制剂中用环加氧酶抑制剂吲哚美辛预孵育会增加 NA 收缩,而在有 PVAT 的 IMA 制剂中用吲哚美辛孵育则不会出现这种情况。从 IMA 周围的 PVAT 释放的前列腺素 E2 (PGE2) 测量值较低,这支持了这些作用。总之,我们的研究结果表明,SV 的 PVAT 可以通过释放 PGE2 和前列环素 (PGI2) 来减弱 NA 诱导的收缩。与 SV 不同,IMA 的 PVAT 通过非前列腺素发挥其抗收缩作用。这些观察结果表明,在人 SV 和 IMA 制剂中保留 PVAT 可能对改善冠状动脉旁路移植术的通畅性具有潜在的临床意义。